ClinicalTrials.gg
RecruitingNCT04478201SLUMBRS2Updated Aug 31, 2023

Comparing the Side-lying Sleep Positioning to Back-lying in Infants With Cleft Palate

An interventional study of back sleep positioning and side sleep positioning in Obstructive Sleep Apnea and Cleft Palate, sponsored by Manchester University NHS Foundation Trust. Recruiting at 11 sites in United Kingdom. Open to participants aged 21 Days to 35 Days. Per ClinicalTrials.gov, last updated 2023-08-31.

Sponsored by Manchester University NHS Foundation Trust · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Jan 2022; still recruiting 4 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
244
Allocation
Randomized
Ages
21 Days to 35 Days
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom — 9 open to participants now, 13 under way, none of them phase 3. Sleep Apnea, Obstructive · United Kingdom.

Planned enrollment
4th of 26
244 · median 58
Started
2022
with 4 others
No phase
21 of 54
3 open now
Primary completion
2024-09
later than 3 of 12 live
Registered
36th of 54
by date

Among the 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom, this one is the 4th largest by planned enrollment of the 26 interventional ones that give a count, is one of 5 that started in 2022, is one of 21 with no phase, reaches primary completion later than 3 of the 12 other live ones, and was the 36th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

9 of the 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 21 Days to 35 Days · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom, or all of them as a file.
02

Study summary

The craniofacial abnormalities found in infants and children with cleft palate (CP) lead to increased risk of obstructive sleep apnoea (OSA). In children and adults sleep position is known to influence the patency of the airway during sleep. Altering sleep position in infants with CP may offer a 'low-cost, high impact' intervention to limit the negative impacts of OSA on child development.

Children with CP are at increased risk of impairment in learning, memory and cognition, with OSA representing an additional risk to cognitive development. Infants with CP are at risk of poor weight gain and 'failure to thrive', which can be further exacerbated by co-existing OSA.

The design and conduct of the proposed randomised controlled trial will benefit from lessons learned from both the feasibility and other previous studies. Investigators demonstrated that existing advice given about sleep position varied significantly with some centres recommending back-lying and others side-lying. Sample size calculations were based on this multi-source data. Parents in the feasibility study knew that sleep position advice for infants with CP changes regularly. They understood why not adhering to 'national guidance' (DoH 2009, Back to Sleep) could be necessary as their infants are "different to normal infants".

How will this study benefit infants with cleft palate and their parents? The proposed study will eliminate the current uncertainty and variability in advice provided to parents of infants with CP, whilst potentially limiting the negative impact of OSA on development. This work has been prioritised and received unanimous support from Cleft Lip and Palate Association (CLAPA), Craniofacial Society Great Britain and Ireland (CFSGBI) and Clinical Nurse Specialists. Aim.To determine the clinical effectiveness in infants with CP of side-lying as compared to back-lying sleep positioning in reducing oxygen desaturation resulting from OSA.

Read the detailed description

The primary aim of this project is to determine the clinical effectiveness in infants with cleft palate (CP) of side-lying as compared to back-lying sleep positioning in reducing oxygen desaturation resulting from obstructive sleep apnoea (OSA). This will be achieved:

  • comparing oxygen saturation during sleep in the side- and back-lying positions at 1 month of age.
  • comparing sleep quality between the side-lying and back-lying groups using a parental questionnaire.
  • co-developing national recommendations with parents regarding sleep position for infants with CP.

A randomised controlled trial (RCT) of side-lying compared with back-lying sleep positioning in reducing oxygen desaturation resulting from OSA in infants with CP. The design and conduct of the study will benefit from lessons learned from the feasibility and other previous studies. All parents in the feasibility study indicated strong interest to participate in further studies evaluating the effects of sleep position. Infants meeting the eligibility criteria will be randomised to side-lying or back-lying in a ratio 1:1 using a minimisation routine incorporating a random element to reduce predictability. Minimisation factors will be clinical site and syndrome suspected or indicated (yes / no). Allocations will be delivered via a password-protected web-based system. The allocated position will only be used on the day(s) when the infant is monitored for the study purposes. Thereafter, parents will be free to revert back to the standard sleep position as advised by their cleft centre, should it be different than that used for the monitoring period. All centres represented at the preparatory meeting with the United Kingdom (UK) Lead Clinical Nurse Specialist group, confirmed that the side-lying position was recommended in some infants at their centre, irrespective of whether it was the standard advice used. As such, all centres had experience of the side-lying position. It was decided not to change the specific advice that centres give to parents regarding how to position the infant in a side-lying position, but any standard written or verbal information would be collected by the study documents.

An internal pilot will investigate participants' opinions about their participation in the study. Using bespoke questionnaires participants' experience will be assessed and it will be decided how it could be improved. After 6 months questionnaire results will be analysed and if necessary study amendments will be put in place to reflect participants' opinions.

Data from the feasibility study and published studies have reported estimates of the standard deviation (SD) of the primary outcome ODI-4 in the side-lying infants at four weeks to range from 8 to 11 units, with a higher SD observed in the back-lying group. The observed difference in mean ODI-4 between the side-lying and back-lying infant cohorts was 15 units (a standardised effect size of 0.91). Investigators considered a smaller but more realistic difference in means of five units to be a clinically important difference (SD 10), a standardised effect size of 0.5. The sample size calculation comparing two means with unequal variances for the primary outcome was, therefore, based on a standardised effect size of 0.5. To account for potential unequal variances in each group a variance ratio of 2 was used in the calculations. To detect a difference of 0.5 standard deviation score (SDS) with 80% power and alpha equal to 0.05 would require 96 infants to be monitored in each arm of the trial (a total of 192 participants). Informed by the multicentre feasibility and oximetry studies the sample size will be inflated to 244 participants in the RCT, to allow for potential attrition of 21%.

This will follow a pre-specified and approved statistical analysis plan. The primary analysis of the RCT data will use intention-to-treat. Baseline data will be analysed to assess the comparability of the demographic and clinical characteristics of the participants. Data from the trial arms will be compared using generalised linear models and adjusted for minimisation covariates where appropriate. Estimates of treatment effect size will be reported as differences in means for continuous outcomes, and risk ratios for dichotomous outcomes and reported along with 95% confidence intervals. Subgroup analyses will explore the effects of sleep position on infants with and without suspected associated syndromes through subgroup treatment interactions, at a stricter alpha level 0.01.

03

Conditions studied

  • Obstructive Sleep Apnea
  • Cleft Palate

Keywords

  • Sleep
  • Sleep position
  • Infants with cleft palate
04

Who can participate

Ages eligible
21 Days to 35 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants diagnosed with an isolated CP under the care of a collaborating centre
  • Infants who are 3 to 5 weeks of age when monitored
  • Parents willing to give consent and able to complete study procedures

Exclusion criteria

Exclusion Criteria:

  • Infants with associated cleft lip
  • Infants born prematurely (before 37 week gestation or up to and including 36 weeks and 6 days)
  • Infants with cardiorespiratory disease
  • Infants requiring an intervention to assist with breathing (nasopharyngeal airway)
  • Infants requiring an intervention to assist with feeding (nasogastric tube)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
244 participants (estimated)

Study arms

  • Experimental
    Back lying sleep position

    sleep on the back

    Other: back sleep positioning

  • Experimental
    Side lying sleep position

    sleep on the side

    Other: side sleep positioning

Interventions

  • Otherback sleep positioning

    sleeping on the back.

  • Otherside sleep positioning

    sleeping on the side

06

What researchers measure

Primary outcomes

  1. Oxygen saturation during sleep at 1 month of age

    Oxygen saturation during sleep at 1 month of age (expressed as 4% oxygen desaturation index, ODI-4). Oximetry is considered the mainstay of assessment of oxygenation in infants and will be the primary outcome measurement instrument. The ODI-4 represents the average number of times that oxygen saturation falls by at least 4% from baseline every hour.

    Time frame: 1 month of age

Secondary outcomes

  1. SPO2 mean

    mean oxygen saturation

    Time frame: completed at 1 month

  2. SPO2 nadir

    nadir oxygen saturation

    Time frame: completed at 1 month

  3. Total sleep time

    the proportion of total sleep time (TST) with oxygen saturation below: 97%, 95%, 90% and 80%

    Time frame: completed at 1 month.

  4. Oxygen saturation during sleep at 1 month of age

    Oxygen saturation during sleep at 1 month of age (expressed as 3% oxygen desaturation index, ODI-3). Oximetry is considered the mainstay of assessment of oxygenation in infants and will be the primary outcome measurement instrument. The ODI-3 represents the average number of times that oxygen saturation falls by at least 3% from baseline every hour.

    Time frame: 1 month of age

  5. Weight

    child's weight

    Time frame: completed at 1 month.

  6. Length

    participant's length

    Time frame: 1 month of age

  7. Head circumference

    participant's head circumference

    Time frame: 1 month of age

  8. Number of participants with Adverse events.

    Number of participants experiencing Adverse events during the trial

    Time frame: From consent for up to 2 weeks

07

Study locations

1 of 11 sites recruiting
08

References and documents

Publications

  • Metryka A, Cuniffe C, Evans HJ, Gavlak JG, Hudson N, Kirby N, Lakhanpaul M, Lin YL, Murray C, Rajai A, Robson H, Schilder A, Walsh T, Bruce I. Study protocol for randomised clinical trial comparing the effectiveness of side-lying sleep positioning to back-lying at reducing oxygen desaturation resulting from obstructive sleep apnoea in infants with cleft palate (SLUMBRS2). BMJ Open. 2021 Apr 7;11(4):e049290. doi: 10.1136/bmjopen-2021-049290. PubMed 33827851 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Sep 2024, 32 months after the start.

Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 32 months is close to that.

Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
May 28, 2020
First posted
Jul 20, 2020
StartActual
Jan 28, 2022
Primary completionEst.
Sep 2024
CompletionEst.
Sep 2024
Last update
Aug 31, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04478201
Collaborators
National Institute for Health Research, United Kingdom, University of Manchester, Centre for Trials Research, Cardiff University, University College, London, Cleft Lip and Palate Association, University Hospital Southampton NHS Foundation Trust, Salisbury NHS Foundation Trust
Responsible party
Sponsor
First posted
Jul 20, 2020
Start date
Jan 28, 2022
Primary completion
Sep 2024 (estimated)
Completion
Sep 2024 (estimated)
Last update
Aug 31, 2023

Study contacts

Ola Metryka
Contact
slumbrs@mft.nhs.uk
+44 (0)161 701 3543
Iain Bruce, Prof
study director · Manchester University NHS Foundation Trust

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion